Innoviva Inc (INVA)
15.98
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
15.99
+0.01
(+0.06%)
After-Hours: 20:00
Innoviva Cash from Investing (Quarterly): -43.04M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -43.04M |
| December 31, 2023 | -5.151M |
| September 30, 2023 | -25.89M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | -35.72M |
| December 31, 2022 | -8.678M |
| September 30, 2022 | 97.72M |
| June 30, 2022 | -2.522M |
| March 31, 2022 | -143.16M |
| December 31, 2021 | -19.90M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 90.02M |
| March 31, 2021 | -26.39M |
| December 31, 2020 | -315.48M |
| September 30, 2020 | -8.50M |
| June 30, 2020 | -7.00M |
| March 31, 2020 | 16.04M |
| December 31, 2019 | 51.99M |
| September 30, 2019 | -15.94M |
| June 30, 2019 | 20.11M |
| March 31, 2019 | -74.17M |
| December 31, 2018 | -45.59M |
| September 30, 2018 | 13.52M |
| June 30, 2018 | 9.078M |
| March 31, 2018 | 26.51M |
| Date | Value |
|---|---|
| December 31, 2017 | -25.88M |
| September 30, 2017 | -21.77M |
| June 30, 2017 | 2.023M |
| March 31, 2017 | 22.40M |
| December 31, 2016 | 23.32M |
| September 30, 2016 | -15.10M |
| June 30, 2016 | -24.50M |
| March 31, 2016 | 11.69M |
| December 31, 2015 | 99.29M |
| September 30, 2015 | -47.88M |
| June 30, 2015 | 34.04M |
| March 31, 2015 | 73.71M |
| December 31, 2014 | -8.411M |
| September 30, 2014 | -59.54M |
| June 30, 2014 | -11.23M |
| March 31, 2014 | 14.13M |
| December 31, 2013 | -1.426M |
| September 30, 2013 | -99.61M |
| June 30, 2013 | -73.53M |
| March 31, 2013 | -45.01M |
| December 31, 2012 | 0.146M |
| September 30, 2012 | -33.71M |
| June 30, 2012 | -33.10M |
| March 31, 2012 | 8.384M |
| December 31, 2011 | 4.547M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-315.48M
Minimum
Dec 2020
97.72M
Maximum
Sep 2022
-19.07M
Average
-7.75M
Median
Cash from Investing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.00 |
| Theriva Biologics Inc | 0.00 |
| Oragenics Inc | -1.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 37.05M |
| Cash from Financing (Quarterly) | -9.165M |
| Free Cash Flow | 152.43M |
| Free Cash Flow Per Share (Quarterly) | 0.4383 |
| Free Cash Flow to Equity (Quarterly) | 36.52M |
| Free Cash Flow to Firm (Quarterly) | 38.22M |
| Free Cash Flow Yield | 11.88% |